Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection

We compared the efficacies of quinupristin-dalfopristin (Q-D; 30 mg/kg of body weight every 8 h) and vancomycin (60 mg/kg twice daily), alone or in combination with rifampin (10 mg/kg twice daily), in a rabbit model of methicillin-resistant Staphylococcus aureus knee prosthesis infection. In contras...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Saleh-Mghir, Azzam, Ameur, Nourdine, Muller-Serieys, Claudette, Ismael, Farid, Lemaitre, Françoise, Massias, Laurent, Feger, Céline, Bléton, Rémy, Crémieux, Anne-Claude
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2002
Assuntos:	Experimental Therapeutics
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127098/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897604/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1122-1124.2002
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!